141 related articles for article (PubMed ID: 2111696)
1. Plasma catecholamine metabolites and polycystic ovary syndrome.
Yoshino K; Takahashi K; Nishigaki A; Eda Y; Kitao M
Asia Oceania J Obstet Gynaecol; 1990 Mar; 16(1):57-62. PubMed ID: 2111696
[TBL] [Abstract][Full Text] [Related]
2. Changes in plasma catecholamines and pulsatile patterns of gonadotropin release in subjects with a normal ovulatory cycle and with polycystic ovary syndrome.
Yoshino K; Takahashi K; Shirai T; Nishigaki A; Araki Y; Kitao M
Int J Fertil; 1990; 35(1):34-9. PubMed ID: 1968442
[TBL] [Abstract][Full Text] [Related]
3. Further evidence concerning catecholamine metabolism in polycystic ovary syndrome following Gn-RH administration.
Yoshino K; Takahashi K; Nishigaki A; Eda Y; Kitao M
Int J Fertil; 1992; 37(2):111-4. PubMed ID: 1349592
[TBL] [Abstract][Full Text] [Related]
4. Evidence for altered catecholamine metabolism in polycystic ovary syndrome.
Shoupe D; Lobo RA
Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):566-71. PubMed ID: 6437227
[TBL] [Abstract][Full Text] [Related]
5. Peripheral catecholamine metabolites and free testosterone in patients with polycystic ovary syndrome.
Yoshino K; Takahashi K; Eda Y; Nishigaki A; Kitao M
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):351-4. PubMed ID: 2045705
[TBL] [Abstract][Full Text] [Related]
6. Peripheral catecholamine metabolites and menstrual irregularity in patients with polycystic ovaries.
Yoshino K; Takahashi K; Eda Y; Nishigaki A; Kitao M
Int J Fertil Menopausal Stud; 1993; 38(4):225-8. PubMed ID: 8401681
[TBL] [Abstract][Full Text] [Related]
7. Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome.
Lobo RA; Granger LR; Paul WL; Goebelsmann U; Mishell DR
Am J Obstet Gynecol; 1983 Feb; 145(4):496-503. PubMed ID: 6824043
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a hypothalamic alteration of catecholamine metabolism in polycystic ovary syndrome.
Paradisi R; Grossi G; Venturoli S; Capelli M; Porcu E; Fabbri R; Pasquali R; Flamigni C
Clin Endocrinol (Oxf); 1988 Sep; 29(3):317-26. PubMed ID: 3251670
[TBL] [Abstract][Full Text] [Related]
9. Changes in brain catecholamine metabolism during bromocriptine treatment in polycystic ovary syndrome.
Paradisi R; Grossi G; Venturoli S; Porcu E; Rocchi G; Pasquali R; Capelli M; Flamigni C
Horm Res; 1993; 39(5-6):223-8. PubMed ID: 8314207
[TBL] [Abstract][Full Text] [Related]
10. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
van der Westhuizen S; van der Spuy ZM
Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
[TBL] [Abstract][Full Text] [Related]
11. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
[TBL] [Abstract][Full Text] [Related]
12. Endocrinological environment with regard to the number of microcysts in patients with polycystic ovary syndrome.
Yoshino K; Takahashi K; Eda Y; Okada S; Kitao M
Hum Reprod; 1992 Oct; 7(9):1201-4. PubMed ID: 1478997
[TBL] [Abstract][Full Text] [Related]
13. Peripheral catecholamine alterations in adolescents with polycystic ovary syndrome.
Garcia-Rudaz C; Armando I; Levin G; Escobar ME; Barontini M
Clin Endocrinol (Oxf); 1998 Aug; 49(2):221-8. PubMed ID: 9828911
[TBL] [Abstract][Full Text] [Related]
14. Which hormone tests for the diagnosis of polycystic ovary syndrome?
Robinson S; Rodin DA; Deacon A; Wheeler MJ; Clayton RN
Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
[TBL] [Abstract][Full Text] [Related]
15. The control of bioactive luteinizing hormone secretion in women with polycystic ovary syndrome.
Lobo RA; Shoupe D; Chang SP; Campeau J
Am J Obstet Gynecol; 1984 Feb; 148(4):423-8. PubMed ID: 6364811
[TBL] [Abstract][Full Text] [Related]
16. Peripheral dopamine metabolism in polycystic ovary syndrome.
Barnes RB; Artal R; Lobo RA
Obstet Gynecol; 1987 Aug; 70(2):153-6. PubMed ID: 3601275
[TBL] [Abstract][Full Text] [Related]
17. Effects of unkei-to, an herbal medicine, on endocrine function and ovulation in women with high basal levels of luteinizing hormone secretion.
Ushiroyama T; Ikeda A; Sakai M; Hosotani T; Suzuki Y; Tsubokura S; Ueki M
J Reprod Med; 2001 May; 46(5):451-6. PubMed ID: 11396371
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
19. Response of gonadotropins to pituitary stimulation with luteinizing hormone releasing hormone is a more specific than sensitive parameter for the polycystic ovary syndrome.
Steck T; Wernze H; Albert PJ
Gynecol Endocrinol; 1991 Dec; 5(4):235-47. PubMed ID: 1796746
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
